Compare · BIB vs DWAW
BIB vs DWAW
Side-by-side comparison of ProShares Ultra Nasdaq Biotechnology (BIB) and AdvisorShares Dorsey Wright FSM All Cap World ETF (DWAW): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIB and DWAW operate in n/a (n/a), so they compete in similar markets.
ProShares Ultra Nasdaq Biotechnology
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
AdvisorShares Dorsey Wright FSM All Cap World ETF
The investment seeks to provide long-term capital appreciation with capital preservation as a secondary objective. The fund is an actively managed exchange-traded fund ("ETF") that is primarily a "fund of funds." The Advisor seeks to achieve it's investment objective by investing in ETFs that invest primarily in domestic and foreign equity securities of any capitalization, including in emerging markets. The fund invests in fixed income ETFs with a short or ultra-short duration, money market funds, cash and cash equivalents ("Defensive Investments"). It may invest in affiliated and unaffiliated ETFs.